Osteoporosis

Patients with prostate cancer may benefit from bone mineral density screenings prior to initiation of therapy, researchers concluded.

The results of a secondary analysis of the FLEX trial do not support regular bone density monitoring within the first few years of discontinuing alendronate therapy.

Supplementation with calcium and vitamin D led to significantly reduced risk of hip fracture when combined with postmenopausal hormone therapy, a recent study finds.

Pharmacists can help their patients determine the best way to meet their daily calcium requirements.

Compared with men whose maternal or paternal grandfather had not broken a hip, grandsons of grandfathers with hip fracture were found to be at a 3% to 5% increased risk of osteoporosis.

A diet low in meat and carbohydrates but with plenty of extra virgin olive oil appears to protect the bones of older men, according to the results of a study.

The generic marketplace remains dynamic and complicated, as patent expirations,interest in biosimilars, and international competition spur major changes.

Less than a quarter know that most fractures in epilepsy patients are unassociated with seizures, according to a recent study.

Postmenopausal women are more likely to start medication therapy following osteoporotic fractures if they receive counseling from a pharmacist, a study suggests.

Pharmacists can advise patients on medications and lifestyle changes to help prevent or treat osteoporosis.

A federal government task force report advised against taking daily vitamin D and calcium supplements to prevent fractures.

Studies suggest minimal improvements after 5 years of bisphosphonate use, and long-term use has been associated with serious, although rare, side effects.

A review of studies suggests long-term hormone replacement therapy increases risk of cancer, cardiovascular problems, and other serious conditions.

Calcium pills that are widely used to help prevent osteoporosis have been associated with a significantly increased risk of heart attack, researchers report.

An implanted chip delivered daily doses of teriparatide, which is usually injected, holding out the promise of implants that can help solve adherence problems.

Intravenous bisphosphonates, often used to treat metastases and bone pain in breast cancer patients, are now being used by clinicians for osteoporosis in these patients—pharmacists need to recommend appropriate screening and treatment.